288 related articles for article (PubMed ID: 15777448)
1. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.
Kuh D; Langenberg C; Hardy R; Kok H; Cooper R; Butterworth S; Wadsworth ME
BJOG; 2005 Apr; 112(4):476-85. PubMed ID: 15777448
[TBL] [Abstract][Full Text] [Related]
2. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.
Matthews KA; Wing RR; Kuller LH; Meilahn EN; Plantinga P
Arch Intern Med; 1994 Oct; 154(20):2349-55. PubMed ID: 7944857
[TBL] [Abstract][Full Text] [Related]
3. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women.
Chang CJ; Wu CH; Yao WJ; Yang YC; Wu JS; Lu FH
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1699-704. PubMed ID: 11126227
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study.
de Kat AC; Dam V; Onland-Moret NC; Eijkemans MJ; Broekmans FJ; van der Schouw YT
BMC Med; 2017 Jan; 15(1):2. PubMed ID: 28049531
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women.
Mandrup CM; Egelund J; Nyberg M; Lundberg Slingsby MH; Andersen CB; Løgstrup S; Bangsbo J; Suetta C; Stallknecht B; Hellsten Y
Am J Obstet Gynecol; 2017 Apr; 216(4):384.e1-384.e11. PubMed ID: 28024987
[TBL] [Abstract][Full Text] [Related]
6. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
7. Climacteric Status at the Age of 46: Impact on Metabolic Outcomes in Population-Based Study.
Savukoski S; Mäkelä H; Auvinen J; Jokelainen J; Puukka K; Ebeling T; Suvanto E; Niinimäki M
J Clin Endocrinol Metab; 2019 Jul; 104(7):2701-2711. PubMed ID: 30753521
[TBL] [Abstract][Full Text] [Related]
8. Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology.
Davis CE; Pajak A; Rywik S; Williams DH; Broda G; Pazucha T; Ephross S
Ann Epidemiol; 1994 Nov; 4(6):445-8. PubMed ID: 7804498
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
Marlatt KL; Redman LM; Beyl RA; Smith SR; Champagne CM; Yi F; Lovejoy JC
Am J Obstet Gynecol; 2020 Apr; 222(4):365.e1-365.e18. PubMed ID: 31610152
[TBL] [Abstract][Full Text] [Related]
10. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight--the Chin-Shan Community Cardiovascular Cohort study.
Torng PL; Su TC; Sung FC; Chien KL; Huang SC; Chow SN; Lee YT
Atherosclerosis; 2002 Apr; 161(2):409-15. PubMed ID: 11888525
[TBL] [Abstract][Full Text] [Related]
11. Progression of Metabolic Syndrome Severity During the Menopausal Transition.
Gurka MJ; Vishnu A; Santen RJ; DeBoer MD
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27487829
[TBL] [Abstract][Full Text] [Related]
12. The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2023; 18(3):e0283393. PubMed ID: 36952503
[TBL] [Abstract][Full Text] [Related]
13. Age at period cessation and trajectories of cardiovascular risk factors across mid and later life.
O'Keeffe LM; Kuh D; Fraser A; Howe LD; Lawlor D; Hardy R
Heart; 2020 Apr; 106(7):499-505. PubMed ID: 32098806
[TBL] [Abstract][Full Text] [Related]
14. Women's health in midlife: the influence of the menopause, social factors and health in earlier life.
Kuh DL; Wadsworth M; Hardy R
Br J Obstet Gynaecol; 1997 Aug; 104(8):923-33. PubMed ID: 9255084
[TBL] [Abstract][Full Text] [Related]
15. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
[TBL] [Abstract][Full Text] [Related]
16. Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women?
Pripp U; Eriksson-Berg M; Orth-Gomér K; Schenck-Gustafsson K; Landgren BM
Gend Med; 2005 Jun; 2(2):88-95. PubMed ID: 16115603
[TBL] [Abstract][Full Text] [Related]
17. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
18. Thyroid function and perimenopausal lipid and weight changes: the Thyroid Study in Healthy Women (TSH-W).
Massoudi MS; Meilahn EN; Orchard TJ; Foley TP; Kuller LH; Costantino JP; Buhari AM
J Womens Health; 1997 Oct; 6(5):553-8. PubMed ID: 9356978
[TBL] [Abstract][Full Text] [Related]
19. Childhood maltreatment and biomarkers for cardiometabolic disease in mid-adulthood in a prospective British birth cohort: associations and potential explanations.
Li L; Pinto Pereira SM; Power C
BMJ Open; 2019 Mar; 9(3):e024079. PubMed ID: 30904846
[TBL] [Abstract][Full Text] [Related]
20. Menopausal status and risk factors for cardiovascular disease.
Peters HW; Westendorp IC; Hak AE; Grobbee DE; Stehouwer CD; Hofman A; Witteman JC
J Intern Med; 1999 Dec; 246(6):521-8. PubMed ID: 10620095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
